EHRA Premium Access

Validation of the peak frequency of bipolar electrograms for detection of residual conduction in atrial scar tissue

Congress Session

About the speaker

Doctor Marcel Martinez Cossiani

La Paz University Hospital, Madrid (Spain)
0 follower

7 more presentations in this session

Comparison between oral procainamide and mexiletine for the treatment of recurrent and refractory ventricular tachyarrhythmias.

Speaker: Doctor M. Toniolo (Udine, IT)

Thumbnail

Is it possible to predict mortality and recurrence of VT afterablation? PAINESD risk score applicability vs new predictors

Speaker: Doctor J. Brito (Lisbon, PT)

Thumbnail

Effectiveness and safety of bipolar ablation of heart arrhythmia. A systematic review with meta-analysis.

Speaker: Doctor M. Farkowski (Warsaw, PL)

Thumbnail

Quantifying the variability of bipolar voltage amplitude with sensing angle in residual conduction isthmuses in atrial scar

Speaker: Doctor M. Martinez Cossiani (Madrid, ES)

Thumbnail

Acute procedural characteristics, efficacy, and safety of a novel cryoballoon for the treatment of paroxysmal atrial fibrillation: Results from the POLAR-ICE study

Speaker: Doctor S. Yap (Rotterdam, NL)

Thumbnail

Access the full session

Moderated ePosters - Variety on how to improve treatment of arrhythmias

Speakers: Doctor M. Martinez Cossiani, Doctor M. Toniolo, Doctor J. Brito, Doctor M. Farkowski, Doctor M. Martinez Cossiani...
Thumbnail

About the event

Image

EHRA 2022

3 April - 5 April 2022

Sessions Presentations

Related content

EHRA Premium Access

Biophysical parameters and time to isolation of pulmonary veins with a novel cryoballoon: results of POLAR ICE study

3 April 2022

EHRA Premium Access

Detection of endo-epicardial atrial low-voltage areas using unipolar and omnipolar voltage mapping

3 April 2022

EHRA Premium Access

Pulsed field ablation of atrial fibrillation: recurrence rate after first pulmonary vein isolation and first insights into durability at redo procedures

3 April 2022

This platform is supported by

logo Novo Nordisk